Segment disclosures

Company overview

PACIRA BIOSCIENCES, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 17 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pcrx:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30192399000 USD20260804Open filing evidence
2026-01-01 – 2026-06-30369775000 USD20260804Open filing evidence
2026-01-01 – 2026-03-31177376000 USD20260430Open filing evidence
2025-01-01 – 2025-12-31726411000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30179516000 USD20251106Open filing evidence
2025-01-01 – 2025-09-30529538000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30181099000 USD20260804Open filing evidence
2025-01-01 – 2025-06-30350022000 USD20260804Open filing evidence
2025-01-01 – 2025-03-31168923000 USD20260430Open filing evidence
2024-01-01 – 2024-12-31700966000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30168573000 USD20251106Open filing evidence
2024-01-01 – 2024-09-30513713000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30178023000 USD20250805Open filing evidence
2024-01-01 – 2024-06-30345140000 USD20250805Open filing evidence
2024-01-01 – 2024-03-31167117000 USD20250508Open filing evidence
2023-01-01 – 2023-12-31674978000 USD20260226Open filing evidence
2022-01-01 – 2022-12-31666823000 USD20250227Open filing evidence